Metastasis News and Research

Metastasis is the spread of cancer from one part of the body to another. A tumor formed by cells that have spread is called a “metastatic tumor” or a “metastasis.” The metastatic tumor contains cells that are like those in the original (primary) tumor. The plural form of metastasis is metastases

Cancer promoting gene identified

21. November 2009 03:08

Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Scientists hope the finding could lead to an effective therapy to target and inhibit the expression of this gene resulting in inhibition of cancer growth. [More]

a969e60e-2a44-43a1-93fd-9632959c223f|0|.0

Posted in: Medical Science News | Medical Condition News

Tags: Angiogenesis, Blood Vessel, Brain, Breast Cancer, Cancer, Cell, Education, Fibroblast, Genetics, Glioblastoma, Glioblastoma Multiforme, Glioma, Liver Cancer, Lung Cancer, Metastasis, Neuroblastoma, Prostate Cancer, Squamous Cell Carcinoma

TGen Drug Development and IPC collaborate to speed up research discoveries for cancer patients

20. November 2009 01:29

TGen Drug Development (TD2) and the Institut Paoli-Calmettes (IPC) have forged a strategic alliance that will enable both to maximize their worldwide contributions in the treatment of cancer patients. [More]

2f2603db-409c-4a0e-a2e0-3705a46f9933|0|.0

Posted in: Medical Condition News | Healthcare News

Tags: Antibody, Biotechnology, Cancer, Diabetes, Education, Genomics, Metastasis, Oncology, Ovarian Cancer, Pancreatic Cancer, Pharmacogenomics

VisEn Medical launches two new agents for imaging quantification

19. November 2009 09:03

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis. [More]

70bfa959-aab3-4833-aec2-08decce222a4|0|.0

Posted in: Device / Technology News | Medical Condition News | Pharmaceutical News

Tags: Arthritis, Biomarker, Bone, Cancer, Metastasis, Microscopy, Osteoporosis

IASLC staging classification: A new approach to evaluate and treat lung cancers

19. November 2009 07:17

The International Association for the Study of Lung Cancer (IASLC) will hold an expert roundtable and Web cast announcing the recent publication and impact of the IASLC's Staging Manual in Thoracic Oncology containing the recently released 7th Edition of TNM in Lung and Pleural Tumours. [More]

053d8ee8-b4ca-435f-9482-c6f7a24eb6e0|0|.0

Posted in: Medical Condition News | Healthcare News

Tags: Cancer, Hospital, Lung Cancer, Metastasis, Oncology

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

19. November 2009 05:42

Colorectal carcinoma is one of the most common cancers in the world. Approximately one in four of these patients have metastases at diagnosis, liver being the most common site involved. Although historically it was considered that liver metastases meant a very poor prognosis, today, due to improved systemic therapy, many patients will be candidates for local hepatic treatments such as surgery or less aggressive radiofrequency ablation. [More]

06c4d10e-b868-48eb-951e-bff731fca4b8|0|.0

Posted in: Medical Procedure News | Medical Condition News

Tags: Cancer, Cirrhosis, Colorectal Cancer, Esophageal Cancer, Gastroenterology, Hepatology, Hospital, Liver Cancer, Metastasis, Oncology, Radiofrequency Ablation

Researchers develop new device with nano-sized features to grab cancer cells

19. November 2009 02:17

Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. [More]

7c97c4aa-ef53-4795-8567-519131b813e6|0|.0

Posted in: Device / Technology News | Medical Science News | Medical Condition News

Tags: Antibody, Biopsy, Breast Cancer, Cancer, Cell, Metastasis, Nanotechnology, Pathology, Pharmacology, Urology

Opiate-based painkillers can increase tumor-cell proliferation, says new study

19. November 2009 01:37

Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. [More]

93413953-874e-4748-8590-f191a2cb10c2|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Anesthesiology, Angiogenesis, Brain, Cancer, Cell, Cell Proliferation, Constipation, Life Expectancy, Lung Cancer, Metastasis, Morphine, Non-Small Cell Lung Cancer, Prostate Cancer, Small Cell Lung Cancer

Way to capture tumor cells in the bloodstream discovered

18. November 2009 07:45

A team led by University of Arkansas for Medical Sciences (UAMS) researchers on the cutting edge of nanotechnology has found a way to capture tumor cells in the bloodstream that could dramatically improve earlier cancer diagnosis and prevent deadly metastasis. [More]

241b366b-a8ff-4361-8e89-08591ae0e79b|0|.0

Posted in: Medical Science News | Medical Condition News

Tags: Cancer, Education, Hospital, Metastasis, Nanotechnology, Otolaryngology, Pathology, Spine, Stroke

Researchers identify new way to capture tumor cells in bloodstream; findings can improve early cancer diagnosis

18. November 2009 07:33

Jin-Woo Kim, a biomedical engineering researcher at the University of Arkansas, is part of a cutting-edge nanotechnology research group that has discovered a way to capture tumor cells in the bloodstream. The work could dramatically improve early cancer diagnosis and prevent deadly metastasis. [More]

c0f899e4-831e-425d-96f3-e96254d3772d|0|.0

Posted in: Medical Science News | Medical Condition News

Tags: Cancer, Metastasis, Nanotechnology, Pathology

Press conference highlights emerging treatments in pancreatic cancer

18. November 2009 03:30

As part of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Thompson will moderate a press conference on emerging treatments in pancreatic cancer on Tuesday, Nov. 17, 2009, in Room 202 of the Hynes Convention Center in Boston, Mass., from 1:00 p.m. to 2:00 p.m. ET. [More]

a8f28545-1bf2-426a-9fe3-eefc360e22ae|0|.0

Posted in: Medical Condition News

Tags: Abraxane, Angiogenesis, Antibody, Avastin, Bevacizumab, Blood Vessel, Cancer, Cell, Chemotherapy, Dermatology, Gemcitabine, Gemzar, Gene Expression, Hospital, Liver Cancer, Metastasis, microRNA, Nanotechnology, Oncology, Paclitaxel, Pancreatic Cancer, Pathology, Photodynamic Therapy, Radiotherapy, VEGF

Phase III randomized clinical trial for Alpharadin to be commenced

18. November 2009 01:30

International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide. [More]

a8f6b274-58d5-4b3d-ab5d-62af15d2a053|0|.0

Posted in: Men's Health News | Drug Trial News

Tags: Anemia, Bone, Bone Marrow, Cancer, Life Expectancy, Metastasis, Prostate Cancer, Urology

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

17. November 2009 08:04

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany. [More]

1e4e8117-84c9-490f-b3e0-d09c1aace944|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Apoptosis, Atopic Dermatitis, Breast Cancer, Cancer, Cell, Dermatitis, Dermatology, Evolution, Liver Cancer, Melanoma, Metastasis, Oncology, Psoriasis, Skin Cancer

Recent developments at Burnham Institute for Medical Research

17. November 2009 04:58

New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases). [More]

a7bd67ba-2c84-4ccf-8674-066aea4a1ec5|0|.0

Posted in: Device / Technology News | Medical Science News

Tags: Antibiotic, Anti-Inflammatory, Blood Vessel, Brain, Cancer, Cell, Diabetes, Hydrogen Peroxide, Immunosuppression, Insulin, Insulin Resistance, Juvenile Diabetes, Metastasis, Neurological Disease, Obesity, Parkinson's Disease, Pathology, Staphylococcus aureus, Stem Cell

ThromboGenics and BioInvent International present phase I results of novel anti-cancer monoclonal antibody

17. November 2009 03:30

ThromboGenics NV and BioInvent International AB today announced positive results from a Phase I trial of their novel anti-cancer monoclonal antibody TB-403 in patients with advanced solid tumours. The results were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, U.S. TB-403 was well tolerated with no reported dose limiting toxicity. These positive data support progression of TB-403 and further development. [More]

a2fd9dc1-d664-4c90-af3a-9bda0ef18b6f|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Angiogenesis, Antibody, Atherosclerosis, Biotechnology, Cancer, Metastasis, Monoclonal Antibody, Thrombosis

Phase II clinical study to evaluate Nanocort commenced

17. November 2009 03:22

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments. [More]

c671443c-7394-49e8-a18e-5988be78afd0|0|.0

Posted in: Drug Trial News

Tags: Antibody, Arthritis, Autoimmune Disease, Bone, Brain, Corticosteroid, Liposome, Metastasis, Multiple Sclerosis, Myelin, Nervous System, Rheumatoid Arthritis, Steroid

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Metastasis News and Research

Cancer promoting gene identified

TGen Drug Development and IPC collaborate to speed up research discoveries for cancer patients

VisEn Medical launches two new agents for imaging quantification

IASLC staging classification: A new approach to evaluate and treat lung cancers

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

Researchers develop new device with nano-sized features to grab cancer cells

Opiate-based painkillers can increase tumor-cell proliferation, says new study

Way to capture tumor cells in the bloodstream discovered

Researchers identify new way to capture tumor cells in bloodstream; findings can improve early cancer diagnosis

Press conference highlights emerging treatments in pancreatic cancer

Phase III randomized clinical trial for Alpharadin to be commenced

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Recent developments at Burnham Institute for Medical Research

ThromboGenics and BioInvent International present phase I results of novel anti-cancer monoclonal antibody

Phase II clinical study to evaluate Nanocort commenced

Recent Articles

Free!

Recent Comments

Twitter

Information

Metastasis News and Research

Medical News Cloud

Recent Articles